These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14656418)

  • 41. Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing.
    Vilibic-Cavlek T; Ljubin-Sternak S; Kolaric B; Kaic B; Sviben M; Kos L; Mlinaric-Galinovic G
    Arch Gynecol Obstet; 2012 Oct; 286(4):901-4. PubMed ID: 22678561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.
    Field N; Amirthalingam G; Waight P; Andrews N; Ladhani SN; van Hoek AJ; Maple PA; Brown KE; Miller E
    Vaccine; 2014 Feb; 32(10):1213-7. PubMed ID: 23871823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroprevalence of varicella antibodies in adults without clinical history of disease.
    Büchele KS; Correa DF; Tuyama M; Lemos ADS; Costa MDD; Mesquita EC; Costa DMD; Cerbino-Neto J; Varela MC; Brasil PEAAD; Brandão LGP
    Cad Saude Publica; 2020; 36(1):e00149119. PubMed ID: 31967286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination.
    Diez-Domingo J; Gil A; San-Martín M; González A; Esteban J; Baldó JM; Planelles MV; Ubeda MI; Graullera M; Peris A; Martínez M; Antón V; Gallego D; Alvarez T; Villarroya JV; Jubert A; Casaní C; Peidró C; García M; Ballester A
    Hum Vaccin; 2005; 1(5):204-6. PubMed ID: 17012857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico.
    Alvarez y Muñoz MT; Torres J; Damasio-Santana L; Gómez A; Fernández-Quintanilla G; Tapia-Conyer R; Muñoz O
    Arch Med Res; 1999; 30(1):60-3. PubMed ID: 10071427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate.
    O'Grady KA; Merianos A; Patel M; Gilbert L
    Trop Med Int Health; 2000 Oct; 5(10):732-6. PubMed ID: 11044268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The utility of serologic testing for varicella in an adolescent population.
    Ronan K; Wallace MR
    Vaccine; 2001 Sep; 19(32):4700-2. PubMed ID: 11535319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Varicella zoster and fever rash surveillance in Lao People's Democratic Republic.
    Nouanthong P; Hübschen JM; Billamay S; Mongkhoune S; Vilivong K; Khounvisith V; Sinner R; Grandadam M; Phonekeo D; Black AP; Muller CP
    BMC Infect Dis; 2019 May; 19(1):392. PubMed ID: 31068140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliability of a history of previous varicella infection in adults.
    Wallace MR; Chamberlin CJ; Zerboni L; Sawyer MH; Oldfield EC; Olson PE; Arvin AM
    JAMA; 1997 Nov; 278(18):1520-2. PubMed ID: 9363973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroepidemiology of varicella in Hangzhou, China in the vaccine era.
    Xu Y; Liu S; Che X; Liu Y; Zhang X; Du J; Zhang X; Wang J; Xu E
    Hum Vaccin Immunother; 2018; 14(10):2464-2471. PubMed ID: 30019992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).
    Thiry N; Beutels P; Shkedy Z; Vranckx R; Vandermeulen C; Wielen MV; Damme PV
    Eur J Pediatr; 2002 Nov; 161(11):588-93. PubMed ID: 12424583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunity to varicella zoster virus in children with leukaemia.
    Ndumbe PM; Wheeler K; Chessells JM; Levinsky RJ
    Med Microbiol Immunol; 1988; 177(2):83-9. PubMed ID: 2834625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Varicella seroprevalence in individuals with a negative or unknown varicella history - results from a large travel clinic in Switzerland between 2008 and 2015.
    Freuler M; De Crom S; Hatz C; Bühler S
    Swiss Med Wkly; 2016; 146():w14342. PubMed ID: 27585235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Seroprevalence of varicella-zoster virus in children with cancer in six hospitals in Santiago, Chile].
    Izquierdo G; Zubieta M; Martínez G MJ; Alvarez AM; Aviles CL; Becker A; Peña M; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Santolaya ME;
    Rev Chilena Infectol; 2012 Dec; 29(6):595-9. PubMed ID: 23412026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of serotesting compared with universal immunization for varicella in refugee children from six geographic regions.
    Figueira M; Christiansen D; Barnett ED
    J Travel Med; 2003; 10(4):203-7. PubMed ID: 12946297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
    Kudesia G; Partridge S; Farrington CP; Soltanpoor N
    J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.